File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ijantimicag.2009.03.008
- Scopus: eid_2-s2.0-67651229521
- PMID: 19376687
- WOS: WOS:000269275100008
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans
Title | Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans | ||||
---|---|---|---|---|---|
Authors | |||||
Keywords | Antifungal susceptibility Biofilm Candida Hyphal mutants | ||||
Issue Date | 2009 | ||||
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag | ||||
Citation | International Journal Of Antimicrobial Agents, 2009, v. 34 n. 4, p. 333-339 How to Cite? | ||||
Abstract | Biofilm formation involving profuse hyphal growth is a major characteristic of Candida spp. and confers higher antifungal resistance than its planktonic mode of growth. We investigated the antifungal susceptibility of Candida albicans and its hyphal mutants (Δefg1/efg1, Δcph1/cph1 and ΔΔcph1/cph1 efg1/efg1) to commonly used antifungals during planktonic, adhesion and biofilm modes of growth. The minimum inhibitory concentration (MIC) of each antifungal agent was determined for a lower inoculum (1 × 10 3 cells/mL) and higher inoculum (1 × 10 7 cells/mL) of planktonic Candida. Furthermore, MICs of C. albicans biofilms and adhesion modes of growth were determined with a standard XTT assay. Candida albicans in adhesion and biofilm modes of growth, but not in planktonic mode, were resistant to all five antifungal agents tested. Although Δefg1/efg1 and ΔΔcph1/cph1 efg1/efg1 mutants formed less biofilm than wild-type C. albicans SC5314, they were similarly resistant to caspofungin. However, these mutants were more sensitive to amphotericin B and nystatin than the wild-type. Adhesion per se confers increased resistance to antifungal agents, which is further pronounced in the biofilm mode of Candida. Filamentation does not appear to be a major determinant of the antifungal resistance in Candida biofilms. © 2009 Elsevier B.V. and the International Society of Chemotherapy. | ||||
Persistent Identifier | http://hdl.handle.net/10722/58033 | ||||
ISSN | 2023 Impact Factor: 4.9 2023 SCImago Journal Rankings: 1.072 | ||||
ISI Accession Number ID |
Funding Information: This work was supported by the Hong Kong Research Grants Council (RGC No. HKU 7624/06M). | ||||
References | |||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Watamoto, T | en_HK |
dc.contributor.author | Samaranayake, LP | en_HK |
dc.contributor.author | Jayatilake, JAMS | en_HK |
dc.contributor.author | Egusa, H | en_HK |
dc.contributor.author | Yatani, H | en_HK |
dc.contributor.author | Seneviratne, CJ | en_HK |
dc.date.accessioned | 2010-05-31T03:22:41Z | - |
dc.date.available | 2010-05-31T03:22:41Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | International Journal Of Antimicrobial Agents, 2009, v. 34 n. 4, p. 333-339 | en_HK |
dc.identifier.issn | 0924-8579 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/58033 | - |
dc.description.abstract | Biofilm formation involving profuse hyphal growth is a major characteristic of Candida spp. and confers higher antifungal resistance than its planktonic mode of growth. We investigated the antifungal susceptibility of Candida albicans and its hyphal mutants (Δefg1/efg1, Δcph1/cph1 and ΔΔcph1/cph1 efg1/efg1) to commonly used antifungals during planktonic, adhesion and biofilm modes of growth. The minimum inhibitory concentration (MIC) of each antifungal agent was determined for a lower inoculum (1 × 10 3 cells/mL) and higher inoculum (1 × 10 7 cells/mL) of planktonic Candida. Furthermore, MICs of C. albicans biofilms and adhesion modes of growth were determined with a standard XTT assay. Candida albicans in adhesion and biofilm modes of growth, but not in planktonic mode, were resistant to all five antifungal agents tested. Although Δefg1/efg1 and ΔΔcph1/cph1 efg1/efg1 mutants formed less biofilm than wild-type C. albicans SC5314, they were similarly resistant to caspofungin. However, these mutants were more sensitive to amphotericin B and nystatin than the wild-type. Adhesion per se confers increased resistance to antifungal agents, which is further pronounced in the biofilm mode of Candida. Filamentation does not appear to be a major determinant of the antifungal resistance in Candida biofilms. © 2009 Elsevier B.V. and the International Society of Chemotherapy. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag | en_HK |
dc.relation.ispartof | International Journal of Antimicrobial Agents | en_HK |
dc.subject | Antifungal susceptibility | - |
dc.subject | Biofilm | - |
dc.subject | Candida | - |
dc.subject | Hyphal mutants | - |
dc.subject.mesh | Antifungal Agents - pharmacology | en_HK |
dc.subject.mesh | Biofilms - drug effects - growth & development | en_HK |
dc.subject.mesh | Candida albicans - drug effects - genetics - growth & development | en_HK |
dc.subject.mesh | Cell Adhesion | en_HK |
dc.subject.mesh | Culture Media | en_HK |
dc.subject.mesh | Drug Resistance, Fungal | en_HK |
dc.subject.mesh | Fungal Proteins - genetics - metabolism | en_HK |
dc.subject.mesh | Gene Expression Regulation, Fungal | en_HK |
dc.subject.mesh | Hyphae - genetics - growth & development | en_HK |
dc.subject.mesh | Microbial Sensitivity Tests | en_HK |
dc.subject.mesh | Mutation | en_HK |
dc.subject.mesh | Plankton - drug effects - growth & development | en_HK |
dc.title | Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_HK |
dc.identifier.email | Seneviratne, CJ:jaya@hku.hk | en_HK |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_HK |
dc.identifier.authority | Seneviratne, CJ=rp01372 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.ijantimicag.2009.03.008 | en_HK |
dc.identifier.pmid | 19376687 | - |
dc.identifier.scopus | eid_2-s2.0-67651229521 | en_HK |
dc.identifier.hkuros | 155468 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-67651229521&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 34 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 333 | en_HK |
dc.identifier.epage | 339 | en_HK |
dc.identifier.isi | WOS:000269275100008 | - |
dc.publisher.place | Netherlands | en_HK |
dc.relation.project | Candida biofilms: molecular mechanisms and clinical implications | - |
dc.identifier.scopusauthorid | Watamoto, T=24171949100 | en_HK |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_HK |
dc.identifier.scopusauthorid | Jayatilake, JAMS=8441671500 | en_HK |
dc.identifier.scopusauthorid | Egusa, H=6602170721 | en_HK |
dc.identifier.scopusauthorid | Yatani, H=7004428080 | en_HK |
dc.identifier.scopusauthorid | Seneviratne, CJ=6701897753 | en_HK |
dc.identifier.citeulike | 5468408 | - |
dc.identifier.issnl | 0924-8579 | - |